Publications

Research Papers -
Impact factor as per Scopus Journal citation reports Jan 2013-01-31 Total times cited 834

  1. Kirwan C, Nolan JM, Stack, J Moore CBT, Beatty S.  Determinants of patient satisfaction and function related to vision following cataract surgery in eyes with no visually consequential ocular co-morbidity. Graefe's Archive for Clinical and Experimental Ophthalmology.  Accepted 22/4/2015 IN Press
  2. Tormey WP, Borovickova I, Moore CBT. Fault lines in forensic medical toxicology in Ireland exposed through replies of pathologists and coroners to anonymous questionnaires. SpringerPlus.2014,3:531.DOI:10.1186/2193-1801-3-531
  3. de Wit D, Diaz J, Moore CBT, Moutari S, Moore JE (2014) Analysis of the effect of position of near add in an asymmetric refractive LENTIS® Mplus LS-312 multifocal intraocular lens on quality of vision.  Journal of Cataract and Refractive Surgery In Press
  4. McGilligan V, Moore JE, Atkinson SD, Moore CBT (2014) A Comparison of the Clinical and Molecular Diagnosis of Herpes Simplex Keratitis. Open Journal of Ophthalmology. Vol 4(3)
  5. Courtney D.G., Atkinson, S.D., Allen, E.H.A., Moore, J.E., Walsh, C.P., Leslie Pedrioli, D.M., Macewen, C.J., Pellegrini, G., Maurizi, E., Serafini, C., Fantacci, M., Liao, H., Irvine, A.D., McLean, W.H.I., Moore, T.C.B. (2014). siRNA Silencing of the Mutant Keratin 12 Allele in Corneal Limbal Epithelial Cells Grown from Patients with Meesmann’s Epithelial Corneal Dystrophy. Invest Ophthalmol Vis Sci. 2014 May 6;55(5):3352-60. doi: 10.1167/iovs.13-12957
  6. Moran S,  Kirwan C, O’Keefe M, Leccisotti A, Moore CBT. (2014) Incidence of dislocated and subluxed iris-fixated phakic intraocular lens and outcomes following re-enclavation. Clinical and Experimental Ophthalmology; DOI:10.1111/ceo.12310.  Impact Factor: 1.96 ranked 18 out of 58 in Ophthalmology.
  7. Courtney DG, Atkinson SD, Moore JE,  Maurizi E, Serafini C, Pellegrini G, Black GC,  Manson F, Hin-Fai Yam G, MacEwen CJ,  Allen EHA, McLean WHI, and Moore CBT (2014)  Development of allele specific gene silencing siRNAs for TGFBI Arg124Cys in Lattice Corneal Dystrophy Type I.  Invest. Ophthalmol. Vis. Sci. 55, 977–85.  DOI 10.1167/iovs.13-13279. Impact factor: 3.441 ranked 4 out of 58 in Ophthalmology.
  8. Moore JE, Atkinson SD, Azar DT, Worthington J, Downes CS, Courtney DG,  Moore CBT (2013) Protection of corneal epithelial stem cells prevents UV-A damage during corneal collagen cross-linking treatment for keratoconus.  Br J Ophthalmol doi:10.1136/bjophthalmol-2013-303816 Impact factor: 2.725 ranked 8 out of 58 in Ophthalmology.
  9. McGilligan VE, Gregory-Ksander MS, Li D, Moore JE, Hodges RR, Gilmore MS, Dartt DA, Moore CBT (2013) Staphylococcus aureus Activates the NLRP3 Inflammasome in Human and Rat Conjunctival Goblet Cells. PLoS ONE, 2013 Sep 10;8(9):e74010. doi: 10.1371/journal.pone.0074010. Impact factor: 3.730 ranked 7 out of 56 in Multidisciplinary Sciences.
  10. Woodcock M, Shah S, Mandal N, Pieger S, Grills C  and Moore CBT (2013) Small Optical Zones with aspheric profiles in Laser Refractive Surgery for Myopia: A Surgical Outcome and Patient Satisfaction Study. Contact Lens and Anterior Eye. 2013 Jun 17. pii: S1367-0484(13)00037-4. doi: 10.1016/j.clae.2013.02.010. Impact Factor: 1.5 ranked 29 out of 58 in Ophthalmology.
  11. Tormey WP, Sabah M and Moore T. (2013) Methadone, codeine and acute haemorrhagic necrotising pancreatitis: Which came first?  Forensic Science International. Vol 226(1-3), pp e52 – e53.  DOI: 10.1016/j.forsciint.2013.01.020 Impact Factor 2.307 ranked 5 out of 16 in Medicine, Legal.
  12. Al-Ojali, S, Moore CBT, Fernandez-Cabezudo, M, Al-Ramadi, B (2013) IFNγ expression by an attenuated strain of Salmonella enterica serovar Typhimurium improves vaccine efficacy in susceptible TLR4-defective C3H/HeJ mice. Medical Microbiology and Immunology, Feb; 202(1):49-61. Impact Factor 3.545 ranked 46 out of 137 in Immunology 
  13. Allen, EHA, Atkinson, Sarah, Liao, H, Moore, J, Leslie Pedrioli, DM, Smith, FJD, McLean, WHI and Moore, T (2013) Allele-specific siRNA silencing for the common Keratin 12 founder mutation in Meesmann epithelial corneal dystrophy. Invest Ophthalmol Vis Sci , 15.  Jan 17;54(1):494-502. Impact Factor 3.441 ranked 4 out of 58 in Ophthalmology.  Cited by 4
  14. Tormey WP, Moore T (2012). Is there a role for ethanol assay using alcohol dehydrogenase in a basic drugs and alcohol screen of blood following routine autopsies? J Clin Pathol Forensic Med; DOI:10.5897/JCPFM12.003.  Impact Factor 2.439 ranked 26 out of 77 in Pathology. 
  15. Tormey WP, Moore TM. (2012) Consensus conferencing in forensic toxicology for the coronial system. Med Leg J. 2012; 80(Pt 4):168-9. Cited by 1
  16. Tormey WP, Srinivasan R, Moore T (2012). Biochemical toxicology and suicide in Ireland: a laboratory study. Ir J Med Sci. 2012 Nov 29. [Epub ahead of print].  Impact Factor 0.506 ranked 116 out of 155 in Medicine – general and internal.  
  17. Tormey WP, Moore TM. (2012) Ethanol as a single toxin in non-traumatic deaths - A toxicology perspective. Leg Med (Tokyo). 2012 Nov 23.. [Epub ahead of print] 
  18. Tormey, William and Moore, Tara (2012) Poisonings and clinical toxicology: a template for Ireland. Irish Journal of Medical Science, May 2012.  Impact Factor 0.506 ranked 116 out of 155 in Medicine – general and internal. Cited by 3
  19. Tormey, W and Moore, T (2012) Diabetes diagnosis and autopsy. Diabetic Medicine, Volume 29, Issue 11, pages 1470–1471.  Impact Factor 3.241 ranked 49 out of 122 in Endocrinology & Metabolism.
  20. Moore, M, Leccisotti, A, Grills, C and Moore, T (2012) Near Visual Acuity Following Hyperopic Photorefractive Keratectomy in a Presbyopic Age Group. ISRN Ophthalmology, 2012 (310474). pp. 1-6. 
  21. Tormey, W, Moore, T and Gulman, C (2012) Cannabis smoking and myocardial infarction. International Journal of Clinical Practice, 66 (2). pp. 226. Impact Factor 2.427 ranked 31 out of 155 in Medicine, General & Internal. Cited by 1   
  22. Moore, JE and Moore, T (2012) Dry Eye Testing In Glaucoma. Glaucoma, 7 (1). pp. 34. Impact Factor: 1.865 ranked 21 out of 58 in Ophthalmology.
  23. Ojali, S, Moore, T, Fernandez-Cabezudo, M and Ramadi, B (2012) Enhancement of the anti-Salmonella immune response in CD154-deficient mice by an attenuated, IFN-expressing, strain of Salmonella enterica serovar Typhimurium. Microbial Pathogenesis, 52 (6). pp. 326-335. Impact Factor 1.974 ranked 104 out of 137 in Immunology 
  24. de Wit, D, Diaz, JM, Moore, T and Moore, JE (2012) Refractive lens exchange for a multifocal intraocular lens with a surface-embedded near section in mild to moderate anisometropic amblyopic patients. Journal of Cataract and Refractive Surgery, Oct;38(10):1796-801. Impact factor: 2.527 ranked 11 out of 58 in Ophthalmology. Cited by 1
  25. Beirne, P, Hall, J, Grills, C and Moore, T (2011) Female Hormone Influences on Sexual Assaults in Northern Ireland form 2002 to 2009. Journal of Forensic and Legal Medicine, 18 (7). pp. 313-316. Impact Factor 0.856 ranked 12 out of 16 in Medicine, Legal.  Cited by 2
  26. Tormey, W and Moore, T (2011) Inconsistent coroner interpretations of cardiac death in the presence of cannabis in urine. Forensic Toxicology, 30(1) pp 84-85.  Impact Factor 3.194 ranked 21 out of 85 in Toxicology. Cited by 2
  27. McLean, WHI and Moore, T (2011) Keratin disorders – from gene to therapy. Human Molecular Genetics. Human Molecular Genetics, Oct 15;20(R2):R189-97. Impact Factor: 7.692 ranked 13 out of 161 in Genetics & Heredity Cited by 23
  28. Clare, G, Moore, T, Grills, C, Leccisotti, A, Moore, J and Schallhorn, S (2011) Early Flap Displacement Following LASIK. Ophthalmology, 118 (9). pp. 1760-1765. Impact Factor 5.563 ranked 1 out of 58 in Ophthalmology for research publications. Cited by 4
  29. Moore, JE, Vasey, GT, Dartt, DA, McGilligan, V, Atkinson, S, Grills, C, Lamey, PJ, Leccisotti, A, Frazer, DG and Moore, T (2011) Effect of tear hyperosmolarity and signs of clinical ocular surface pathology upon conjunctival goblet cell function in the human ocular surface. Investigative Ophthalmology & Visual Science, 52 (9). pp. 6174-6180. Impact Factor: 3.441 ranked 4 out of 58 in Ophthalmology Cited by 9
  30. Atkinson, S, McGilligan, V, Liao, H, Szeverenyi , I, Smith , FJ, Moore, T and McLean, WH (2011) Development of Allele-Specific Therapeutic siRNA for Keratin 5 Mutations in Epidermolysis Bullosa Simplex. JID, Oct;131(10):2079-86. Impact Factor: 6.193 ranked 1 out of 59 in Dermatology.  This paper was identified by Faculty of 1000, a post publication peer review faculty who select papers important in its field.   Cited by 15
  31. Liao, H, Irvine, AD, MacEwen, CJ, Weed, KH, Porter, L, Corden, LD, Gibson, AB, Moore, JE, Smith, FJD, McLean, WHI and Moore, T (2011) Development of allele-specific therapeutic siRNA in Meesmann epithelial corneal dystrophy. PLoS ONE, 6 (12). pp. e28582. Impact factor: 3.73 ranked 7 out of 56 in Multidisciplinary Sciences.  Cited by 12
  32. McAlinden, C, Moore, J, McGilligan, V and Moore, T (2010) Spherical aberration and higher order aberrations with Balafilcon A (PureVision) and Comfilcon A (Biofinity). . Graefe's Archive for Clinical and Experimental Ophthalmology, 249 (2). pp. 607-612. Impact Factor 1.932 ranked 19 out of 58 in Ophthalmology Cited by 5
  33. Ayoubi, MG, Leccisotti, A, McGilligan, V, Goodall, EA and Moore, T (2010) Femtosecond LASIK versus conductive keratoplasty to obtainmonovision in presbyopic emmetropes. Journal of Cataract & Refractive Surgery, 36 (6). pp. 997-1002. Impact factor: 2.527 ranked 11 out of 58 in Ophthalmology.  Cited by 8
  34. Rowan, P, Hill, M, Gresham, GA, Goodall, E and Moore, T (2010) The use of Infrared Aided Photography in Identification of Sites of Bruises after Evidence of the Bruise is Absent to the Naked Eye. Journal of Forensic and Legal Medicine , 17 (6). pp. 293-297. Impact Factor 0.856 ranked 12 out of 16 in Medicine, Legal. Cited by 6
  35. Ludlow, M, Rennick, L J., Sarland, S, Skibinski, G, McQuaid, S, Moore, T, de Swart, R L. and Duprex, W.P (2010) Wild-type measles virus infection of primary epithelial cells occurs via the basolateral surface without syncytium formation or release of infectious virus. Journal of General Virology, 91 pp. 971-979. Impact factor: 3.127 ranked 11 out of 32 in virology. Cited by 23
  36. Reynolds, A, Moore, J E, Naroo, S A, Moore, T and Shah, S (2010) Excimer laser surface ablation – a review. Journal of Clinical and Experimental Ophthalmology, 38 pp. 168-1882. Impact factor: 1.964 ranked 18 out of 58 in Ophthalmology.  Cited by 18
  37. Leccisotti, A, Islam, T, McGilligan, V and Moore, T (2010) Phacoemulsification after deep anterior lamellar keratoplasty . Eur J Ophthalmol, 20. pp. 680-683. Impact factor: 0.916 ranked 44 out of 58 in Ophthalmology. Cited by 2
  38. Carey, P, Leccisotti, A, McGilligan, V, Goodall, E and Moore, T (2010) Assessment of toric intraocular lens alignment by OPD Scan and Slit lamp observation.. Journal of Cataract & Refractive Surgery, 36. pp. 222-229. Impact factor: 2.527 ranked 11 out of 58 in Ophthalmology Cited by 20
  39. Goodall, E. A., Moore, J. and Moore, T (2009) The estimation of approximate sample size requirements necessary for clinical and epidemiological studies in vision sciences. EYE, 23 (7). pp. 1589-1597. 1597 Impact factor: 1.818 ranked 22 out of  58 in Ophthalmology. Cited by 3
  40. Novitskaya, E S., McGilligan, V, Moore, JE., Sharma, A, Dean, SJ. and Moore, T (2009) Difficulties Imaging Herpes Simplex Keratitis With Fluorescein Isothiocynate-Labeled Anti-HSV-1 Antibodies in an Ex Vivo Model. Cornea, 28 (4). pp. 421-425. Impact factor: 1.746 ranked 23 out of 58  in Ophthalmology.  
  41. Novitskaya, ES., Dean, SJ., Moore, JE., Moore, T, Nagendran, S and Sharma, A (2009) Effects of some ophthalmic medications on pupil size: a literature review. Canadian Journal of Ophthalmology – Journal Canadien D Ophthalmologie, 44 (2). pp. 193-197. Impact factor 1.145 ranked 38 out of 58  in Ophthalmology Cited by 4
  42. Maguire, W, Goodall, E and Moore, T (2009) Injury in adult female sexual assault complainants and related factors. European Journal of Obstetrics and Gynecology and Reproductive Biology, 142 (2). pp. 149-153. Impact Factor 1.843 ranked 34 out of 78 in Obstetrics & Gynaecology. Cited by 13
  43. Graham, J. E., Moore, J. E., Goodall, E. A., Dartt, D. A., Leccisotti, A., McGilligan, V. E. and Moore, Tara (2009) Concordance between common dry eye diagnostic tests. British Journal of Ophthalmology, 93 (1). pp. 66-72. Impact factor: 2.725 ranked 8 out of 58 in Ophthalmology Cited by 25
  44. Novitskaya, E. S., Moore, J. E., Athanasiadis, Y., Moore, Tara and Sharma, A. (2009) A highly sensitive technique for imaging and effective monitoring of staining of the ocular surface defects.  EYE, 23 (1). pp. 234-235. Impact factor: 1.818 ranked 22 out of 58 in Ophthalmology.
  45. Graham, JE., McGilligan, V, Berrar, D, Leccisotti, A, Moore, JE., Bron, AJ. and Moore, T (2009) Attitudes towards Diagnostic Tests and Therapies for Dry Eye Disease. Ophthalmic Research, 43 (1). pp. 11-17. Impact factor: 1.562 ranked 27 out of 58 in Ophthalmology.  Cited by 2
  46. Hall, JA, Goodall, E and Moore, T (2008) Alleged drug facilitated sexual assault (DFSA) in Northern Ireland from 1999 to 2005. A study of blood alcohol levels. Journal of Forensic and Legal Medicine, 15. pp. 497-504. Impact Factor 0.856 ranked 12 out of 16 in Medicine, Legal. Cited by 14
  47. Graham, JE., Moore, JE., Moore, J., McClurg, RB. and Moore, T (2008) Cross contamination of hospital ophthalmic slit lamps by ocular bacteria. American Journal of Infection Control, 36 (8). pp. 605-606. Impact factor: 2.731 ranked 30 out of 70 in infectious diseases.
  48. Stevenson , TR, Goodall, EA and Moore, T (2008) A retrospective audit of the extent and nature of domestic violence cases identified over a three year period in the two District Command Units of the Police Service of Northern Ireland. Journal of Forensic and Legal Medicine, 15. pp. 430-436. Impact Factor 0.856 ranked 12 out of 16 in Medicine, Legal. Cited by 1
  49. Hall, JA and Moore, T (2008) Drug facilitated sexual assault – A review. Journal of Forensic and Legal Medicine, 15. pp. 291-297. Impact Factor 0.856 ranked 12 out of 16 in Medicine, Legal. Cited by 26
  50. Atkinson, S, Moore, JE., Shah, S, Sharma, A, Best, RM., Leccisotti, A, Alarbi, M, Rimmer, D, Gardiner, T and Moore, T (2008) P63 expression in conjunctival proliferative diseases: Pterygium and laryngo-onycho-cutaneous (LOC) syndrome. Current Eye Research, 33 (7). pp. 551-558. Impact factor: 1.710 ranked 25 out of 58 in Ophthalmology.  Cited by 6
  51. Graham, JE, Graham, RLJ, Beirne, R, McGilligan, V, Downes, S, Moore, JE, Moore, T and McMullan, G (2008) The Use of Conjunctival Swab for the Proteomic Characterisation of Dry Eye Syndrome. Journal of Proteomics and Bioinformatics, 1. pp. 20-33. Cited by 1
  52. Cathcart, M E. H., McGrath, P, Goodall, E and Moore, T (2008) An investigation of the interface between the office of the police ombudsman for Northern Ireland and local forensic physicians. Medicine Science and the Law, 48 (2). pp. 117-123. Impact Factor 0.484 ranked 15 out of 16 in Medicine, Legal.   
  53. Burns, A, Goodall, E and Moore, T (2008) A study of suicides in Londonderry, Northern Ireland, for the year period spanning 2000–2005. Journal of Forensic and Legal Medicine, 15. Impact Factor 0.856 ranked 12 out of 16 in Medicine, Legal. Cited by 9
  54. Dean SJ, Novitskaya, ES., Moore, T, Moore, JE. and Sharma, A (2008) Documentation of corneal epithelial defects with fluorescein-enhanced digital fundus camera photography. Clinical and Experimental Ophthalmology, 36 (2). pp. 113-118. Impact factor: 1.964 ranked 18 out of 58 in Ophthalmology Cited by 2
  55. Payne-James, JJ, Green, PG, Green, M, McLachlan, GMC, Munro, MHWN and Moore, T (2008) Healthcare issues of detainees in police custody in London, UK . Journal of Forensic and Legal Medicine, 17. Impact Factor 0.856 ranked 12 out of 16 in Medicine, Legal. Cited by 18
  56. Graham, JE., Moore, JE., Jiru, X, Moore, J., Goodall, E A., Dooley, J S. G., Hayes, V, Dartt, D A., Downes, S and Moore, T (2007) Ocular pathogen or commensal: A PCR-based study of surface bacterial flora in normal and dry eyes. Investigative Ophthalmology & Visual Science, 48 (12). pp. 5616-5623. Impact factor: 3.441 ranked 4 out of 58 in Ophthalmology. Cited by 38
  57. Novitskaya, ES, Dean, SJ, Moore, JE, Moore, T and Sharma, A (2007) A novel method to study fluorescein staining of the ocular surface using the fluorescein angiogram setting of the fundus camera. Contact Lens and Anterior Eye, 30. pp. 258-259. Impact Factor 1.461 ranked 32 out of 58 in Ophthalmology. Cited by 3
  58. Kaji, Y, Usui, T, Ishida, S, Yamashiro, K, Moore, T, Moore, J, Yamamoto, Y, Yamamoto, H and Adamis, AP. (2007) Inhibition of diabetic leukostasis and blood-retinal barrier breakdown with a soluble form of a receptor for advanced glycation end products. Investigative Ophthalmology & Visual Science, 48 (2). pp. 858-865. Impact factor: 3.441 ranked 4 out of 58 in Ophthalmology. Cited by 61
  59. Usui, T, Isbida, S, Yamasbiro, K, Kaji, Y, Poulaki, V, Moore, J, Moore, T, Shima, DT and Adamis, AP (2004) VEGF(164(165)) as the pathological isoform: Differential leukocyte and endothelial responses through VEGFR1 and VEGFR2. Investigative Ophthalmology & Visual Science, 45 (2). pp. 368-374. Impact factor: 3.441 ranked 4 out of 58 in Ophthalmology. Cited by 105
  60. Moore, TC, Moore, JE, Kaji, Y, Frizzell, N, Usui, T, Poulaki, V, Campbell, IL, Stitt, AW, Gardiner, TA, Archer, DB  and Adamis AP (2003) The role of advanced glycation end products in retinal microvascular leukostasis. Investigative Ophthalmology & Visual Science, 44 (10). pp. 4457-4464. Impact factor: 3.441 ranked 4 out of 58 in Ophthalmology. Cited by 99
  61. Moore, JE, McMullen TC, Campbell, IL, Rohan, R, Kaji, Y, Afshari, NA, Usui, T, Archer, DB and Adamis, AP (2002) The inflammatory milieu associated with conjunctivalized cornea and its alteration with IL-1 RA gene therapy. Investigative Ophthalmology & Visual Science, 43 (9). pp. 2905-2915. Impact factor: 3.441 ranked 4 out of 58 in Ophthalmology. Cited by 39
  62. Moore, JE, McMullen, CBT, Mahon, G and Adamis, AP (2002) The corneal epithelial stem cell. DNA and Cell Biology, 21 (5-6). pp. 443-451. Impact Factor 2.072 Ranked 102 out of 158 in Genetics & Heredity Cited by 51
  63. Stitt, AW, Burke, GA, Chen, F, McMullen, CBT and Vlassara, H (2000) Advanced glycation end-product receptor interactions on microvascular cells occur within caveolin-rich membrane domains. Faseb Journal, 14 (15). pp. 2390-2392. Impact factor 5.704. Ranked 7 out of 83 in Biology Cited by 48
  64. Stitt, AW, Bhaduri, T, McMullen, CBT, Connolly, J, Gardiner, TA and Archer, DB (2000) Advanced Glycation End Products Induce Blood–Retinal Barrier Dysfunction in Normoglycemic Rats. Molecular Cell Biology Research Communications, Jun;3(6):380-8 Cited by 76
  65. McMullen, T, Fleming, E, Clarke, G and Armstrong, MA (2000) The Role of Reactive Oxygen Intermediates in the Regulation of Cytokine-Induced ICAM-1 Surface Expression on Endothelial Cells. Molecular Cell Biology Research Communications, Apr;3(4):231-7. Cited by 13
  66. Donaldson, EA, McKenna, DJ, McMullen, T, Scott, WN, Stitt, AW and Nelson, J (2000) The Expression of Membrane-Associated 67-kDa Laminin Receptor (67LR) Is Modulated in Vitro by Cell-Contact Inhibition. Molecular Cell Biology Research Communications, Jan;3(1):53-9. Cited by 22

Professional Publications

  1. Shah S, McAlinden C, Leccisotti A, Moore JE, McConville D, Moore T. Clinical Governance & Medicolegal Issues. Cataract and refractive surgery today Europe, 2009; Sept: 83-84
  2. Shah S, McAlinden C, Leccisotti A, Moore JE, McConville D and Moore CBT. Complications of Refractive Surgery. Cataract and Refractive Surgery 2009;4(2):68-69
  3. Shah S, McAlinden C, Leccisotti A, Moore JE, McConville D, Moore T. Cataract Surgery Coursework. Cataract and refractive surgery today Europe, 2009; May: 77-79
  4. Shah S, McAlinden C, Leccisotti A, Moore JE, McConville D, Moore T. Correction of Presbyopia. Cataract and refractive surgery today Europe, 2009; March: 69-73
  5. Shah S, McAlinden C, Leccisotti A, Moore JE, McConville D, Moore T. Review of two courses: correcting regular and irregular astigmatism, phakic IOLs. Cataract and refractive surgery today Europe, 2008; 3(7): 92-64.
  6. Shah S, McAlinden C, Leccisotti A, Moore JE, McConville D, Moore T. Excimer laser refractive surgery. Cataract and refractive surgery today Europe, 2008; 3(5): 61-63.
  7. Shah S, McAlinden C, Leccisotti A, Moore JE, McConville D, Moore T. Preoperative assessment in refractive surgery. Cataract and refractive surgery today Europe, 2008; 3(4): 76-78.
  8. Shah S, McAlinden C, Leccisotti A, Moore JE, McConville D, Moore T. Past and present refractive techniques. Cataract and refractive surgery today Europe, 2008; 3(3): 80-82.
  9. Shah S, Moore JE, Leccisotti A, McConville D, Moore CBT, Cataract, Refractive E-Learning Course Cataract and refractive surgery today Europe, 2008; 3(2): 83-85
  10. Shah S. Leccisotti A. Moore JE. Moore CBT. E Learning could solve Refractive Surgery Training Dilemma. Aiming for Worldwide Excellence in Cataract and Refractive Surgery. Ophthalmology Times Europe. November 1 p29-30 2007 Edition www.ophthalmologytimes.com

Books

  1. BM Hannigan, CBT Moore and DG Quinn: Immunology second edition, Scion 2009.
  2. University of Ulster: Perspectives on Pedagogy and Practice, Volume 1, September 2010.
  3. E.A. Goodall, J. Moore, M.B. Goodall, C.T. Moore: Biometrics of Astigmatism in the Human Eye, blueberrypublishing 2014.

Publications from presentations at Conferences for Ocular Research Group

  1. Moore JE, Dartt DA, Vasey GT, McGilligan VE, Atkinson S, Grills C, Lamey PJ and Moore T. Effect of Increasing Tear Osmolarity and Dry Eye Severity on Goblet Cell Population in the Human Ocular Surface. Invest Ophthalmol Vis Sci 2011;52: E-Abstract 3788.
  2. Vasey GT, Moore JE, McGilligan VE, Aktinson SD, Farrell S, Grills C and Moore CBT. A Comparison Of Dry Eye Diagnostic Tests Within An Optometric Population. Invest Ophthalmol Vis Sci 2011;52: E-Abstract 3859.
  3.  Moore CBT, Liao H, Irvine A, Porter LF, Gibson B, Corden L, MacEwen C, Weed KH, Moore JE and McLean WH. Development of Allele-specific Therapeutic siRNA In Meesmann Epithelial Corneal Dystrophy. Invest Ophthalmol Vis Sci 2011;52: E-Abstract 1113.
  4. Atkinson SD, McGilligan VE, Moore JE, Tallouzi M, Feeney S,  Sharma A, Shah S, Jackson J, Frazer DG and Moore CBT. A Comparison Of The Clinical And Molecular Diagnosis Of Herpes Simplex Keratitis. Invest Ophthalmol Vis Sci 2011;52: E-Abstract 6630.
  5. Atkinson, S; McGilligan, VE; Liao, H; Moore, TC; McLean, WHI. Allele-specific siRNA therapy for epidermolysis bullosa simplex.  Society of Investigative Dermatology, Edinburgh, Scotland. British Journal of Dermatology 162(4):926-926 (2010)
  6. McGilligan VE, Atkinson SA, Liao H, Moore TC, McLean WHI. Mutation-specific siRNA therapy for epidermolysis bullosa simplex. Society of Investigative Dermatology, Atlanta, USA (2010) (poster presentation) http://sid.abstractcentral.com/viewer Journal of Investigative Dermatology 130546-546 (2010)  
  7. JE Graham, JE Moore, DA Dartt, R Best, M Alarbi, S McGimpsy, Y Diebold, CS Downes, JE Moore & T Moore.  Ocular Surface Bacterial Flora – A Conundrum. (abstract) International Conference European Association for Vision and Eye Research (EVER), 2006. www.ever.be  Acta Ophthalmologica Scandinavica Volume 84, October 2006, Suppl 239
  8. JE Graham, JE Moore, DA Dartt, R Best, M Alarbi, S McGimpsey, Y Diebold, CS Downes, CBT Moore. Staphylococcus epidermidis: Friend or Foe in Dry Eye, its Interaction with Conjunctival Goblet Cells. (abstract) International Conference European Association for Vision and Eye Research (EVER), 2006. www.ever.be  Acta Ophthalmologica Scandinavica Volume 84, October 2006, Suppl 239
  9. JE Moore, JE Graham, DA Dartt, EA Goodall & CBT. Moore.  Which is more difficult: the Test to Use or the Diagnosis of Dry Eye. (abstract) International Conference European Association for Vision and Eye Research (EVER), 2006. www.ever.be  Acta Ophthalmologica Scandinavica Volume 84, October 2006, Suppl 239
  10. JE. Graham, JE. Moore, X Jiru, JE. Moore, E Goodall, J Dooley, DA. Dartt, SC. Downes, TCB. Moore.  Pathogen or commensal: a pcr based study of ocular surface bacterial flora in normal and dry eyes. (abstract) 5th International Conference, tear film & ocular surface: basic science and clinical relevance, TFOS. 2007. Acta Ophthalmologica Scandinavica. Volume 85, September 2007; Suppl 240
  11. JE Moore, JE Graham, E Goodall, DA Dartt, A Leccisotti, SC Downes, TCB  Moore.  Correlation between diagnostic tests guides the development and use of a dry eye diagnostic algorithm. (abstract) 5th International Conference, tear film & ocular surface: basic science and clinical relevance, TFOS. 2007. Acta Ophthalmologica Scandinavica Volume 85, September 2007, Suppl 240
  12. VE MGilligan, JE. Graham, JE Moore, G McMullan, RLJ Graham, RO Beirne, SC. Downes, TCB. Moore.  Proteomic analysis of conjucntival swab by mass spectrometry. (abstract) 5th International Conference, tear film & ocular surface: basic science and clinical relevance, TFOS. 2007.  Acta Ophthalmologica Scandinavica, Volume 85, September 2007, Suppl 240
  13. JE Moore, JE Graham, RO Beirne, SC Downes and CBT Moore. The effect of post-operative antibiotics on the ocular surface bacterial flora in cataract patients Acta Ophthalmologica Scandinavica Volume 85 September 2007, Suppl 240 
  14. McGilligan VE, Graham JE, Moore JE, McMullan G, Graham RLJ, Beirne RO, Downes CS, Moore TCB.  Proteomic analysis of conjucntival swab by mass spectrometry.  EVER, Slovenia (2007) www.ever.be (poster presentation) Acta Ophthalmologica Scandinavica, Volume 85, September 2007, Suppl 240
  15. Moore JE, Small DM, Graham JE, Atkinson SD, Meenan BJ, Lui C, Downes CS & Moore CBT. Ocular cell growth, protein absorption & cytokine expression analysis on modified surfaces, Journal for Research in Experimental and Clinical Ophthalmology, Ophthalmic Research, Vol 36 s1 p1467, 2004
  16. Corneal Gene Therapy with IL-1 RA Inhibits Corneal Neovascularisation & Suppresses Rejection in Penetrating Keratoplasty. Afshari NA., McMullen CBT., Moore JE., Campbell IL., Usis T., Haskova Z., Kasander B. & Adamis AP. (Investigative Ophthalmology & Visual Science, 2002)
  17. The Role of Advanced Glycation End-Products (AGEs) in Retinal Microvascular Leukostasis McMullen CBT., Moore JE., FRCOphth., Kaji Y., Frizzell N., Usui T., Poulaki V., Campbell IL., Afshari NA., Stitt AW., Archer DB., & Adamis AP. (Investigative Ophthalmology & Visual Science, 2002).
  18. The Inflammatory Milieu Associated with Comjunctivalised Cornea and Its Alteration Using IL-1 RA Gene Therapy. Moore JE., McMullen CBT., Campbell IL., Rohan R., Afshari NA., Kaji Y. Usui T., Archer DB. & Adamis AP. (Investigative Ophthalmology and Visual Science 2002).
  19. Basement Membrane Immobilised AGEs Induce Capillary Endothelial Dycfunction and Apoptosis. Frizzell N., Gardiner TA., McMullen CBT., Thorpe SR., Brown V. & Stitt AW. (IOVS 2002).
  20. Advanced Glycation End-product mediated Activation of adhesion molecules in retinal vascular cells:implications for leukostasis during diabetic retinopathy. N. Frizzell CBT McMullen DB Archer & AW Stitt. Diabetes UK annual professional conference SECC Glasgow April 2001
  21. Advanced Glycation End-Products Increase Expression Of Adhesion Molecules By The Retinal Vascular Endothelium In Vitro and In Vivo: Implications For Leukostasis In Diabetic Retinopathy. McMullen CBT., Simpson DAC., Frizzell N., Brown V., Archer DB. and Stitt AW. Investigative Ophthalmology & Visual Science 41 (4): S406-S406 2145B391 Suppl. S.
  22. Stitt AW., Burke GA., McMullen CBT., Chen F. & Vlassara H. (2000) Advanced Glycation End-Product Receptor Interactions on Microvascular Cells Within Caveolae. Diabetes 49 (1) A48-A49.
  23. McFarlane, S; McMullen, CBT; Henry, DN; Mahon, G; Archer, DB; Stitt, AW.  Advanced glycation endproducts (AGEs) modulate cathepsin D expression in retinal pigment epithelium (RPE): Implications for age related dysfunction.  Investigative Ophthalmology & Visual Science, 41 (4):2189B435  Suppl. S 2000.  
  24. Antisense to the receptor for AGE inhibits AGE–mediated proliferation in vascular endothelial cells. McMullen CBT., Simpson DAC. and Stitt AW. (1999) Diabetic Medicine 16 (1) p33.
  25. Activation of NFkB in retinal vascular cells after short-term exposure to AGEs. Mc Mullen CBT., Jamison PM., Archer DB. & Stitt AW.1999 IOVSVol. 40 No. 4: S607-S607 3191B49  p19149.
  26. Glucose activation of NfkappaB in vascular smooth muscle cells. Mc Mullen CBT., Yue KKM., Anderson P., Sharpe PC. & Trimble ER. Diabetologia 1998 Vol. 41 No. S1 p87.
  27. NFKappaB and AP-1 are activated by glucose in vascular smooth muscle cells. Yue KKM., Mc Mullen CBT., Anderson PA. & Trimble ER DIABETOLOGIA 41: A24-A24 87 Suppl. 1  1998 
  28. Inhibition of endothelial NF Kappa B by antioxidant inhibits IL-1B induced activation but not activation by HSV-1. Mc Mullen CBT., Clarke GF., Fleming E. & Armstrong MA. Immunology 1996 Vol. 89 No.S1 f56.

National And International Presentations

Conference – Oral Presentations For Ocular Research Group

Invited Presentations for Ocular Research Group

  1. 2015 Invited Speaker Darwin Society, Cambridge University
  2. 2015 Key Note Speaker at OxFest, Oxford University
  3. 2015 Guest Speaker, Science Event, Belfast
  4. 2015 Inspirational Speaker, Belfast
  5. 2014 Invited presentation Ocular Surface inflammation and corneal pathology – what are the targets for therapy? Vision TRG Meeting Belfast.
  6. 2014 Invited presentation Development of allele specific gene silencing siRNAs for TGFBI Arg124Cys in Lattice Corneal Dystrophy Type 1. Vision TRG Meeting Belfast.
  7. 2013 Development of allele specific siRNA for Corneal Dystrophy and assessment in an ex vivo model using patient limbal stem cells. BIT’s World Gene Convention on 14th November, Haikou, China.
  8. 2012 Moore CBT Therapeutic siRNA gene silencing for the ocular surface. Invited speaker at Seminar series, Faculty of Medicine and Health Sciences, United Arab Emirates University, Al Lin, UAE.
  9. 2013 Moore CBT Guest Speaker at the student-led Symposium for PhD Students in the Centre For Infection and Immunity, Queen's University Belfast.  29th May 2013.

Oral Presentations for Ocular Research Group

  1. 2014 Development of allele specific gene silencing siRNAs for TGFBI Arg124Cys in Lattice Corneal Dystrophy Type I. ARVO on 7th May, Orlando, USA.
  2. 2014 Development of Allele-specific Therapeutic siRNA for Meesmann's Epithelial Corneal Dystrophy.  20-21 March 2014.  6th Ocular Diseases & Drug Discovery Conference, San Diego
  3. 2014 Development of allele specific gene silencing siRNAs for TGFBI Arg124Cys in Lattice Corneal Dystrophy Type I. Northern Ireland Infection & Immunity TRG Meeting on 25th February, Belfast, UK.
  4. 2014 Development of allele specific gene silencing siRNAs for TGFBI Arg124Cys in Lattice Corneal Dystrophy Type. Vision TRG meeting Belfast.
  5. 2013 Identifying Potent and Specific siRNAs for Allele Specific Gene Silencing in Diseases Following a Dominant Negative Pathomechanism. BIT’s World Gene Convention on 14th November, Haikou, China.
  6. 2013 Assessment of allele-specific gene silencing siRNAs in an ex vivo pre-clinical model of lattice type I corneal dystrophy.  Irish Society of Human Genetics 2013 Scientific Meeting on 6th September, Belfast City Hospital.
  7.  2013 Multifocals in macular disease.  BSRS Annual Congress 29th June 2013, The Belfry, West Midlands.
  8. 2012 Mutation-specific siRNA therapy for a keratin disorder. Irish Society of Human Genetics Annual Scientific Meeting 3rd September 2012, Royal College of     Surgeons in Ireland.
  9. 2012 S10 Mutation-specific siRNA therapy for a keratin disorder.  Irish Society of Human Genetics Annual Scientific Meeting, 3rd September 2012, Royal College of Surgeons in Ireland.
  10. 2012 RNA interference treatment, using eye drops, validated using Meesmann’s corneal dystrophy. The XIV Bowman Club Annual Meeting, Newcastle, UK.
  11. 2011 Expression of NALP3 inflammasome components in human and rat conjunctival goblet cells.  ARVO Fort Lauderdale, USA.
  12. 2007 Pathogen or commensal: a pcr based study of ocular surface bacterial flora in normal and dry eyes. International Tear Film and Ocular Surface Conference in Sicily.
  13. 2006 Ocular Surface Bacterial Flora - A Conundrum European Association for Vision and Eye Research (EVER) International Conference, Portugal
  14. 2006 Staphylococcus epidermidis: Friend or Foe in Dry Eye, its Interaction with Conjunctival Goblet Cells European Association for Vision and Eye Research (EVER) International Conference, Portugal
  15. 2005 Efficacy of an in-vivo antibody based assay for the detection of herpes simplex keratitis. Ophthalmology 7th Alumni Meeting Belfast Royal Victoria Hospital, Belfast NI.
  16. 2004    The Analysis of Bacterial Flora In Dry Eye International Tear Film and Ocular Surface Conference in Puerto Rico.
  17. 2004    Comparison of routine bacteriology culture to molecular detection methods for analysis of ocular bacterial flora. The 4th international conference on the lacrimal gland, tear film, ocular surface and dry eye syndrome: Basic Science and clinical relevance, Fajardo, Puerto Rico.
  18. 2004    Herpes Simplex Keratitis Research Project Recognised Research Group Infectious Diseases NI.
  19. 2004    The effect of atmospheric plasma surface treatment of poly (methyl methacrylate) PMMA on corneal epithelial cell growth, protein absorption and cytokine expression’. European Association for Vision & Eye Research, Vilamoura, Portugal.
  20. 2004 The effect of atmospheric plasma surface treatment of poly(methyl methacrylate) PMMA on corneal epithelial cell growth, protein absorption and cytokine expression’.UK Society for Biomaterials, 3rd Conference, University of Brighton, UK.
  21. 1999    Antisense to the receptor for AGE inhibits AGE-mediated proliferation in Vascular Endothelial Cells” presented at Faculty of Medicine & Health Sciences Research Meeting.
  22. 1999    Laboratory Research Techniques” presented to Institute of Continuing Education.
  23. 1998    Nuclear Factor Kappa Beta and Activator Protein 1 are Activated by Glucose in Vascular Smooth Muscle Cells” presented at the European Association for Study of Diabetes meeting, Barcelona.
  24. 1998    Glucose Activation of Nuclear Factor Kappa Beta in Vascular Smooth Muscle Cells” presented at the American Diabetic association Annual Meeting, Chicago, USA.
  25. 1997 Nuclear Factor Kappa Beta – an Overview” presented to Department of Clinical Biochemistry, QUB,

Conference Poster Presentations For Ocular Research Group

  1. 2014 Moore JE, Courtney DG, Atkinson SD, Maurizi E, Nesbit A, Pellegrini G, Azar DT, McLean WHI and Moore CBT. Identifying the role of matrix metalloproteinases in the pathomechanism of TGFBI Arg124Cys related Lattice Corneal Dystrophy Type I. Arvo on 4th May, Orlando USA.
  2. 2014 Nesbitt A, Moore CBT.  Development of Novel Therapeutic Approaches to Corneal Disease.  14th March.  Vision TRG, Belfast.
  3. 2014 Atkinson SD, Courtney DG,  Allen EHA, Moore JE, Walsh CP, Leslie Pedrioli DM, MacEwen CJ, Pellegrini G, Maurizi E, Serafini C, Fantacci M, Liao H, Irvine AD, McLean WHI and Moore CBT. Development of Allele-specific Therapeutic siRNA Keratin 12 Leu132Pro in Meesmann's Epithelial Corneal Dystrophy.  14th March.  Vision TRG, Belfast.
  4. 2014 Allen EHA,  Lamond AI, McLean WHI, Moore CBT.  Development of a gene suppression and replacement therapy for Meesmann’s  Epithelial Corneal Dystrophy Vision TRG Meeting Belfast. 
  5. 2014 Moore JE, Atkinson SD, Azar DT, Worthington J, Downes CS, Courtney DG, Moore CBT. Protection of corneal epithelial stem cells prevents ultraviolet A damage during corneal collagen cross-linking treatment for keratoconus.  14th March.  Vision TRG, Belfast.
  6. 2014 Moore JE, Beirne R, Sharma A and Moore CBT. The use of the LENTIS Mplus multifocal IOL in patients with macular problems. Vision TRG, Belfast.
  7. 2013  SD Atkinson, AHM Heagerty, IM Leigh, C Pourreyron, I Szeverenyi, FJ Smith, CBT Moore, WHI McLean.  Development of therapeutic siRNA for an epidermolysis bullosa simplex causing mutation in keratin 5.  Irish Society of Human Genetics 2013 Scientific Meeting on 6th September, Belfast City Hospital
  8.  2013 DG Courtney, SD Atkinson, EHA Allen, JE Moore, CP Walsh, CJ MacEwen, E Maurizi, G Pellegrini, WHI McLean and CBT Moore.  siRNA mediated allele specific knockdown of mutant Keratin 12 in a preclinical ex vivo MECDmodel.  Irish Society of Human Genetics 2013 Scientific Meeting on 6th September, Belfast City Hospital.
  9. 2013 Moore J, de Wit DW, Diaz JM and Moore CBT. Refractive Lens Exchange for Multifocal IOL with Surface-Embedded Near Section in Mild to Moderate Anisometropic Amblyopic Patients.  ASCRS Symposium, April 2013, San Fransico, USA
  10. 2012 Atkinson, SD, McGilligan, VE, Liao, H, Irvine, I, Porter, LF, Gibson, Corden, LD, MacEwen, CJ, Weed, KH, Moore, JE, Szeverenyi, I, Smith, FJ, McLean, WHI, Moore, CBT. Development of Allele-specific Therapeutic siRNA. C-TRIC TMED4 Conference 10th & 11th May 2012, City Hotel, Derry.     
  11.  2012 Allen, EHA,  Atkinson, SD, Meehan, B, Liao, H, Irvine, A, Porter, LF, Gibson, B, Corden, LD, MacEwen, CJ, Weed, KH, Moore, JE, Smith, FJ, McLean, WHI, Moore, CBT.  Allele specific siRNA as a potential therapy for corneal dystrophy.  Irish Society of Human Genetics Annual Scientific Meeting,  3rd September 2012, Royal College of Surgeons in Ireland.
  12.  2011 Moore CBT,, Liao H, Irvine AD, MacEwen CJ, Weed KH, Porter L, Corden LD, Moore JE, McLean WHI.  Development of allele-specific therapeutic siRNA in Meesmann epithelial corneal dystrophy.  Irish College of Ophthalmologists Annual Conference, Cavan, May 2011.
  13.  2011 Moore JE, GT Vasey, Dartt DA, Mc Gilligan VE, Atkinson SD, Grills C, Lamey PJ, Leccisotti A , Frazer DG, Twaih S, Moore CBT. Effect of tear hyperosmolarity and signs of clinical ocular surface pathology upon conjunctival goblet cell function in the human ocular surface.   Irish College of Ophthalmologists Annual Conference, Cavan, May 2011
  14.  2011 CBT More, Liao H, Irvine AD, MacEwen CJ, Weed KH, Porter L, Corden LD, Moore JE, McLean WHI.  Development of allele-specific therapeutic siRNA in Meesmann epithelial corneal dystrophy.  ARVO Fort Lauderdale May 2011.
  15.  2011 Vasey GT, Moore JE, McGilligan VE, Aktinson SD, Farrell S, Grills C, Moore TC.  A Comparison Of Dry Eye Diagnostic Tests Within An Optometric Population.  ARVO Fort Lauderdale May 2011.
  16.  2011 Atkinson SD,  McGilligan VE, Moore JE, Tallouzi M, Feeney S, Sharma A, Shah S, Jackson JA, Frazer DG, Moore TC  A comparison of the clinical and molecular diagnosis of herpes simplex.  ARVO Fort Lauderdale May 2011.
  17.  2011 Moore JE, Dartt DA, Vasey GT, McGilligan VE, Atkinson S, Grills C, Lamey PJ, Moore TC.  Effect of Increasing Tear Osmolarity and Dry Eye Severity on Goblet Cell Population in the Human Ocular Surface.  ARVO Fort Lauderdale May 2011.
  18. 2007 McGilligan VE, Graham JE, Moore JE, McMullan G, Graham RLJ, Beirne RO, Downes CS, Moore TCB.  Proteomic analysis of conjucntival swab by mass spectrometry. TFOS, Sicily (2007)
     http://www.tearfilm.org/content/taormina/taobook.pdf
  19. 2007 McGilligan VE, Graham JE, Moore JE, McMullan G, Graham RLJ, Beirne RO, Downes CS, Moore TCB.  Proteomic analysis of conjucntival swab by mass spectrometry. EVER, Slovenia (2007) www.ever.be
  20. 2007 McGilligan VE, Graham JE, Moore JE, McMullan G, Graham RLJ, Beirne RO, Downes CS, Moore TCB.  Proteomic analysis of conjucntival swab by mass spectrometry. Infectious Diseases RRG Annual Meeting, Ballycastle, N. Ireland (2007)
  21. 2007 McGilligan VE, Novitskaya ES, Moore JE, Sharma A, Dean SJ, Moore TC. Difficulties imaging herpes simplex keratitis with fluorescein isothiocynate-labeled anti-HSV-1 antibodies in an ex vivo model. Infectious Diseases RRG Annual Meeting, Ballycastle, N. Ireland (2007)
  22. 2007 McGilligan VE, Graham JE, Moore JE, McMullan G, Graham RLJ, Beirne RO, Downes CS, Moore TCB.  Proteomic analysis of conjucntival swab by mass spectrometry. Vision Science RRG Annual Meeting, Ballymena, N. Ireland (2007)
  23. 2007 McGilligan VE, Novitskaya ES, Moore JE, Sharma A, Dean SJ, Moore TC. Difficulties imaging herpes simplex keratitis with fluorescein isothiocynate-labeled anti-HSV-1 antibodies in an ex vivo model. Vision Science RRG Annual Meeting, Ballymena, N. Ireland (2007)
  24. 2007    Pathogen or commensal: a pcr based study of ocular surface bacterial flora in normal and dry eyes. International Tear Film and Ocular Surface Conference in Sicily.
  25. 2007    Correlation between diagnostic tests guides the development and use of a dry eye diagnostic algorithm.  International Tear Film and Ocular Surface Conference in Sicily.
  26. 2007    Proteomic analysis of conjucntival swab by mass spectrometry  International Tear Film and Ocular Surface Conference in Sicily.
  27. 2006    Staphylococcus epidermidis: Friend or Foe in Dry Eye, it’s Interaction with Conjunctival Goblet Cells.  British Society for Immunology-Pathogen Interaction with the Immune System Meeting, Stranmillis University College, Belfast
  28. 2006    Ocular Surface Bacterial Flora - A Conundrum.  British Society for Immunology-Pathogen Interaction with the Immune System Meeting, Stranmillis University College, Belfast.
  29. 2006    Staphylococcus epidermidis: Friend or Foe in Dry Eye, its Interaction with Conjunctival Goblet Cells.  European Association for Vision and Eye Research (EVER) International Conference, Portugal
  30. 2006    Ocular Surface Bacterial Flora - A Conundrum.  European Association for Vision and Eye Research (EVER) International Conference, Portugal
  31. 2006    Which is more difficult: the Test to Use or the Diagnosis of Dry Eye.  European Association for Vision and Eye Research (EVER) International Conference, Portugal
  32. 2006    Ocular Surface Bacterial Flora - A Conundrum.  Infectious Diseases RRG Annual Meeting, Ballycastle, N. Ireland
  33. 2005 Efficacy of an in-vivo antibody based assay for the detection of herpes simplex keratitis. Moore JE, Yeung I, Sharma A, Gardiner T, Frazer D, O'Neill H, White S, Jackson J, Moore CBT. Ophthalmology 7th Alumni Meeting Belfast Royal Victoria Hospital, Belfast NI.
  34. 2005    The Analysis of Bacterial Flora In Dry Eye Society of General Microbiology meeting University of Ulster, Coleraine.
  35. 2005 Moore JE, Atkinson S, Shah S, Sharma A, Page B, Best R, Alarbi M & Moore T. Expression of P63 in Normal and Diseased Ocular Surface Tissue. Ophthalmology 7th Alumni Meeting, Belfast NI.
  36. 2004    Comparison of routine bacteriology culture to molecular detection methods for analysis of ocular bacterial flora. The 4th international conference on the lacrimal gland, tear film, ocular surface and dry eye syndrome: Basic Science and clinical relevance, Fajardo, Puerto Rico, USA.
  37. 2004    Herpes Simplex Keratitis Research Project Recognised Research Group Infectious Diseases NI.
  38. 2004    The effect of atmospheric plasma surface treatment of poly (methyl methacrylate) PMMA on corneal epithelial cell growth, protein absorption and cytokine expression’.European Association for Vision & Eye Research, Vilamoura, Portugal.
  39. 2004 The effect of atmospheric plasma surface treatment of poly(methyl methacrylate) PMMA on corneal epithelial cell growth, protein absorption and cytokine expression’.UK Society for Biomaterials, 3rd Conference, University of Brighton, UK.
  40. 2004    The Analysis of Bacterial Flora In Dry Eye.  International Tear Film and Ocular Surface Conference in Puerto Rico.
  41. 2004    The effect of atmospheric plasma surface treatment of poly(methyl methacrylate) PMMA on corneal epithelial cell growth and protein absorption  Moore JE, Small DM, Graham JE, Atkinson SD,  Meenan BJ, Lui C, Downes CS & Moore CBT. UK Society for Biomaterials, University of Brighton, UK.
  42. 2002    The Role of Advanced Glycation End-Products (AGEs) in Retinal Microvascular Leukostasis   McMullen CBT., Moore JE., FRCOphth., Kaji Y., Frizzell N., Usui T., Poulaki V., Campbell   IL., Afshari NA., Stitt AW., Archer DB., & Adamis AP. Presented at the Association for Research in Vision & Ophthalmology, (ARVO) Fort Lauderdale, Florida USA.
  43. 2002    Corneal Gene Therapy with IL-1 RA Inhibits Corneal Neovascularisation & Suppresses Rejection in Penetrating Keratoplasty. Afshari NA., McMullen CBT., Moore JE., Campbell IL., Usis T., Haskova Z., Kasander B. & Adamis AP. Presented at the ARVO, Florida USA.
  44. 2002    The Inflammatory Milieu Associated with Comjunctivalised Cornea and Its Alteration Using IL-1 RA Gene Therapy. Moore JE., McMullen CBT., Campbell IL., Rohan R., Afshari NA., Kaji Y. Usui T., Archer DB. & Adamis AP Presented at  ARVO Fort Lauderdale, Florida USA.
  45. 2002    Basement Membrane Immobilised AGEs Induce Capillary Endothelial Dycfunction and Apoptosis. Frizzell N., Gardiner TA., McMullen CBT., Thorpe SR., Brown V. & Stitt AW. Presented at ARVO Fort Lauderdale, Florida USA.
  46. 2001    N Frizzell, CBT McMullen, DB Archer & AW Stitt. Advanced Glycation End-product mediated Activation of adhesion molecules in retinal vascular cells:implications for leukostasis during diabetic retinopathy. Presented at the Diabetes annual professional conference SECC Glasgow.
  47. 2000    Stitt AW., Burke GA., McMullen CBT., Chen F. & Vlassara H. 2000 Advanced Glycation End-Product Receptor Interactions on Microvascular Cells Occur Within The Caveolae Membrane System. Presented at the American diabetic association meeting in San Diego.
  48. 2000    McMullen CBT., Simpson DAC., Frizzell N., Brown V., Archer DB. and Stitt AW. Advanced Glycation End-Products Increase Expression Of Adhesion Molecules By The Retinal Vascular Endothelium In Vitro and In Vivo: Implications For Leukostasis In Diabetic Retinopathy. Presented at ARVO USA.
  49. 2000    McFarlane S., McMullen CBT., Henry DN., Mahon G., Archer DB. & Stitt AW. Advanced Glycation End-Products modulate cathepsin D expression in retinal pigment epithelium:Implications for age-related dysfunction. Presented at ARVO Florida USA.
  50. 2000    McFarlane S., McMullen CBT., Henry DN., Mahon G., Archer DB. & Stitt AW. Advanced Glycation End-Products modulate cathepsin D expression in retinal pigment epithelium:Implications for age-related dysfunction. Presented at the Faculty of Medicine & Health Sciences Research Meeting.
  51. 1999    Mc Mullen CBT., Jamison PM., Archer DB. & Stitt AW. Activation of NFkB in retinal vascular cells after short-term exposure to AGEs. Presented at ARVO, Fort Lauderdale, Florida USA.
  52. 1999    McMullen CBT., Simpson DAC. and Stitt AW Antisense to the receptor for AGE inhibits AGE-mediated proliferation in Vascular Endothelial Cells presented at Annual Faculty of Medicine meeting QUB.
  53. 1999    Simpson DAC., McMullen CBT., Archer DB. & Stitt AW. A Profile of the Genes Involved in Cell Interactions which are Expressed in Human Dermal Microvascular Endothelial Cells & the Effect of Advanced Glycation End-Products. Presented at the Faculty of Medicine & Health Sciences Research
  54. 1999    McMullen CBT., Simpson DAC. and Stitt AW Antisense to the receptor for AGE inhibits AGE–mediated proliferation in vascular endothelial cells. Presented at the Annual Spring meeting of the British Diabetic Association, Glasgow.
  55. 1999    Antisense to the receptor for AGE inhibits AGE-mediated proliferation in Vascular Endothelial Cells” presented at Faculty of Medicine & Health Sciences Research Meeting.
  56. 1999    Laboratory Research Techniques” presented to Institute of Continuing Education.
  57. 1998    Nuclear Factor Kappa Beta and Activator Protein 1 are Activated by Glucose in Vascular Smooth Muscle Cells” presented at the European Association for Study of Diabetes meeting, Barcelona.
  58. 1998    Glucose Activation of Nuclear Factor Kappa Beta in Vascular Smooth Muscle Cells” presented at the American Diabetic association Annual Meeting, Chicago, USA.
  59. 1997 Nuclear Factor Kappa Beta – an Overview” presented to Department of Clinical Biochemistry, QUB, 
  60. 1995    Mc Mullen CBT., Clarke GF., Fleming E. & Armstrong MA Inhibition of endothelial NF Kappa B by antioxidant inhibits IL-1B induced activation but not activation by HSV-1. Presented at the British Biochemical & Immunology Society meeting Harrogate.

 

Tara Moore, PhD

Director of the Biomedical Sciences Research Institute

 

  • :+44 28 70124577
  • DEPARTMENTUniversity of Ulster
  • COUNTRYUSA